INMB · INmune Bio Inc. Common stock
View on chartInsiders & Stakes
| Tesi Raymond Joseph President and CEO | ▲ Buy | Open Market | 1,554,106 Shares held | 9/12/2024 | View profile |
| Lowdell Mark William Chief Scientific Officer | ▲ Buy | Option Exercise | 1,518,017 Shares held | 7/2/2026 | View profile |
| Moss David J CFO, Treasurer & Secretary | ▲ Buy | Option Exercise | 1,294,883 Shares held | 7/2/2026 | View profile |
| Juda Scott Director | ▲ Buy | Option Exercise | 86,404 Shares held | 7/2/2026 | View profile |
| Schroeder Timothy j Director | ▼ Sell | Open Market | 82,187 Shares held | 7/12/2023 | View profile |
| Ganjei James Kelly Director | ▲ Buy | Grant | 17,793 Shares held | 3/22/2022 | View profile |
Transaction History
| Juda Scott | ▲ Buy | Option Exercise | 14,801 | $21K | 7/2/2026 |
| Lowdell Mark William | ▲ Buy | Option Exercise | 7,211 | $10K | 7/2/2026 |
| Moss David J | ▲ Buy | Option Exercise | 9,014 | $13K | 7/2/2026 |
| Moss David J | ▲ Buy | Open Market | 10,000 | $53K | 9/30/2024 |
| Tesi Raymond Joseph | ▲ Buy | Open Market | 15,380 | $98K | 9/12/2024 |
| Moss David J | ▲ Buy | Open Market | 7,690 | $49K | 9/12/2024 |
| Juda Scott | ▲ Buy | Open Market | 5,000 | $36K | 6/25/2024 |
| Tesi Raymond Joseph | ▲ Buy | Grant | 18,028 | $150K | 4/19/2024 |
| Moss David J | ▲ Buy | Grant | 18,028 | $150K | 4/19/2024 |
| Lowdell Mark William | ▲ Buy | Grant | 14,423 | $120K | 4/19/2024 |
| Juda Scott | ▲ Buy | Grant | 29,603 | $246K | 4/19/2024 |
| Juda Scott | ▲ Buy | Open Market | 7,000 | $49K | 11/10/2023 |
| Schroeder Timothy j | ▼ Sell | Open Market | 10,000 | $110K | 7/12/2023 |
| Moss David J | ▲ Buy | Open Market | 2,500 | $16K | 3/17/2023 |
| Moss David J | ▲ Buy | Open Market | 3,000 | $20K | 5/27/2022 |
| Tesi Raymond Joseph | ▲ Buy | Open Market | 6,300 | $40K | 5/26/2022 |
| Moss David J | ▲ Buy | Open Market | 7,700 | $48K | 5/26/2022 |
| Lowdell Mark William | ▲ Buy | Grant | 23,590 | $199K | 3/22/2022 |
| Tesi Raymond Joseph | ▲ Buy | Grant | 23,724 | $200K | 3/22/2022 |
| Moss David J | ▲ Buy | Grant | 17,793 | $150K | 3/22/2022 |
| Ganjei James Kelly | ▲ Buy | Grant | 17,793 | $150K | 3/22/2022 |
| Juda Scott | ▲ Buy | Open Market | 2,500 | $34K | 11/17/2021 |
| Lowdell Mark William | ▼ Sell | Open Market | 701 | $14K | 11/3/2021 |
| Moss David J | ▼ Sell | Open Market | 1,025 | $21K | 11/3/2021 |
| Tesi Raymond Joseph | ▼ Sell | Open Market | 3,626 | $73K | 11/3/2021 |
| Tesi Raymond Joseph | ▼ Sell | Open Market | 6,517 | $130K | 10/27/2021 |
| Lowdell Mark William | ▼ Sell | Open Market | 2,357 | $47K | 10/27/2021 |
| Moss David J | ▼ Sell | Open Market | 2,079 | $42K | 10/27/2021 |
| Moss David J | ▼ Sell | Open Market | 13 | $260 | 10/25/2021 |
| Tesi Raymond Joseph | ▼ Sell | Open Market | 23,616 | $472K | 10/22/2021 |
| Moss David J | ▼ Sell | Open Market | 1,142 | $23K | 10/22/2021 |
| Lowdell Mark William | ▼ Sell | Open Market | 400 | $8K | 10/22/2021 |
| Tesi Raymond Joseph | ▲ Buy | Option Exercise | 30,000 | $117K | 8/25/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
INmune Bio Announces Attendance at 2026 Maxim Growth Summit
INmune Bio said it will attend the 2026 Maxim Growth Summit. The event is a platform for biotech companies to meet investors and partners. Attendance may raise the company’s profile and open new collaboration opportunities. The stock is currently trading near the lower end of its 52‑week range.
INmune Bio Announces Attendance at 2026 Maxim Growth Summit. INmune Bio said it will attend the 2026 Maxim Growth Summit. The event is a platform for biotech companies to meet investors and partners. Attendance may raise the company’s profile and open new collaboration opportunities. The stock is currently trading near the lower end of its 52‑week range.